Novelion Therapeutics Inc, (NVLN) News Today → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free NVLN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17, 2024 | finance.yahoo.comDenali Therapeutics Inc. (DNLI)May 11, 2024 | finance.yahoo.comIntellia Therapeutics, Inc. (NTLA)April 21, 2024 | finance.yahoo.comVoyager Therapeutics, Inc. (VYGR)April 18, 2024 | investing.comVivos Therapeutics Inc (VVOS)March 24, 2024 | morningstar.comCentury Therapeutics Inc IPSCFebruary 14, 2024 | wsj.comCymaBay Therapeutics Inc.February 6, 2024 | investing.comAclaris Therapeutics Inc (ACRS)January 3, 2024 | investing.comHighTide Therapeutics Inc (2511)December 30, 2023 | investing.comIntensity Therapeutics Inc (INTS)December 17, 2023 | morningstar.comLeap Therapeutics Inc LPTXNovember 14, 2023 | morningstar.comAileron Therapeutics Inc ALRNNovember 11, 2023 | morningstar.comAtossa Therapeutics Inc ATOSNovember 1, 2023 | morningstar.comBeam Therapeutics Inc BEAMNovember 1, 2023 | morningstar.comAprea Therapeutics Inc APRENovember 1, 2023 | morningstar.comCelldex Therapeutics Inc CLDXOctober 31, 2023 | morningstar.comCARISMA Therapeutics Inc CARMSeptember 29, 2023 | finance.yahoo.comIs Viking Therapeutics, Inc. a Buy?August 26, 2023 | seekingalpha.comIMUN Immune Therapeutics, Inc.August 24, 2023 | seekingalpha.comELVN Enliven Therapeutics, Inc.May 10, 2023 | morningstar.comSigilon Therapeutics Inc Ordinary SharesApril 25, 2023 | finance.yahoo.comSarepta Therapeutics, Inc. (SRPT)April 20, 2023 | morningstar.comNurix Therapeutics Inc Ordinary SharesApril 20, 2023 | seekingalpha.comZVSA ZyVersa Therapeutics, Inc.March 26, 2023 | finanznachrichten.deDefence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 MillionFebruary 26, 2023 | benzinga.comWindtree Therapeutics Stock (NASDAQ:WINT), Quotes and News SummaryJanuary 28, 2023 | seekingalpha.comFDMT 4D Molecular Therapeutics, Inc.January 27, 2023 | seekingalpha.comAVTE Aerovate Therapeutics, Inc.January 24, 2023 | seekingalpha.comRUBY Rubius Therapeutics, Inc.January 24, 2023 | seekingalpha.comCOEP Coeptis Therapeutics Holdings, Inc.January 14, 2023 | businesswire.comFATE ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Fate Stockholders and Encourages Investors to Contact the FirmSeptember 29, 2022 | fool.comAlaunos Therapeutics, Inc. (NASDAQ: TCRT) Get Novelion Therapeutics Inc, News Delivered to You Automatically Sign up to receive the latest news and ratings for NVLN and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NVLN Media Mentions By Week NVLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVLN News Sentiment▼0.001.21▲Average Manufacturing News Sentiment NVLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVLN Articles This Week▼00▲NVLN Articles Average Week Get Novelion Therapeutics Inc, News Delivered to You Automatically Sign up to receive the latest news and ratings for NVLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:NVLN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novelion Therapeutics Inc, Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
